Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Mant

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|June 14, 2017
Early antiretroviral therapy reduces HIV DNA following perinatal HIV infectionCaroline Foster, Matthew Pace, Steve Kaye, et al.
Biopreservation and Biobanking|October 7, 2011
How Representative Are Research Tissue Biobanks of the Local Populations? Experience of the Infectious Diseases Biobank at King's College, London, UKZisis Kozlakidis, Christine Mant, Barry Peters, et al.
Antiviral Therapy|October 14, 2015
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)Lisa Hamzah, Juan M Tiraboschi, Helen Iveson, et al.
Mbio|September 25, 2023
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infectionJeffrey Seow, Zayed A Shalim, Carl Graham, et al.
AIDS Research and Human Retroviruses|December 6, 2016
Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut ReservoirJuan Tiraboschi, Shuvra Ray, Kemal Patel, et al.
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Cell Reports|April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variantsJeffrey Seow, Carl Graham, Sadie R Hallett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
Nature Medicine|September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine|August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|June 14, 2017
Early antiretroviral therapy reduces HIV DNA following perinatal HIV infectionCaroline Foster, Matthew Pace, Steve Kaye, et al.
Biopreservation and Biobanking|October 7, 2011
How Representative Are Research Tissue Biobanks of the Local Populations? Experience of the Infectious Diseases Biobank at King's College, London, UKZisis Kozlakidis, Christine Mant, Barry Peters, et al.
Antiviral Therapy|October 14, 2015
Effects on vitamin D, bone and the kidney of switching from fixed-dose tenofovir disoproxil fumarate/emtricitabine/efavirenz to darunavir/ritonavir monotherapy: a randomized, controlled trial (MIDAS)Lisa Hamzah, Juan M Tiraboschi, Helen Iveson, et al.
Mbio|September 25, 2023
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infectionJeffrey Seow, Zayed A Shalim, Carl Graham, et al.
AIDS Research and Human Retroviruses|December 6, 2016
Short Communication: Lack of Effect of Maraviroc Intensification on Blood and Gut ReservoirJuan Tiraboschi, Shuvra Ray, Kemal Patel, et al.
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Cell Reports|April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variantsJeffrey Seow, Carl Graham, Sadie R Hallett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19Magdalene Joseph, Yin Wu, Richard Dannebaum, et al.
Nature Medicine|September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Nature Medicine|August 19, 2020
A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Pageof 3